Four weeks ago, the University of California staggered out bruised but largely victorious from its patent dispute with Genentech over a human growth hormone. Yet the university still faced the prospect of having to fight over the same issues in faraway Indiana, which Genentech insisted was the proper pugilistic venue. UC lawyers now say that recent Supreme Court rulings have so broadly immunized state universities from patent lawsuits that the Indiana suit is now kaput.
June 29, 1999 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
When a patent dispute over the rich rights to a human growth hormone ended four weeks ago in San Francisco federal court, the University of California staggered out bruised but largely victorious.
Jurors tossed out opponent Genentech Inc.’s claim that UC’s 1982 patent wasn’t enabled, or adequate for use by other scientists. And they deadlocked 8-1 in favor of UC’s claim that Genentech had infringed on the school’s patent.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
